Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Acquir Immune Defic Syndr ; 75(1): 77-80, 2017 05 01.
Article in English | MEDLINE | ID: mdl-28198711

ABSTRACT

Longitudinal opioid prescription use is unknown among HIV-infected patients. Group-based trajectory modeling followed by multinomial logistic regression was used to identify distinct trajectories and their association with baseline characteristics among 1239 HIV-infected UNC CFAR HIV Clinical Cohort participants, 2000-2014. Three trajectories were identified: (1) 72% never/sporadic opioid use (referent group), (2) 11% episodic use (associated with female sex, depression, drug-related diagnoses, antiretroviral therapy use, and undetectable HIV RNA), and (3) 16% chronic use (associated with older age, female sex, and mental health diagnoses). Overall, opioid prescription decreased substantially with longer time in HIV care among both episodic and chronic users.


Subject(s)
Analgesics, Opioid/administration & dosage , HIV Infections/complications , Substance-Related Disorders/epidemiology , Adult , Female , Humans , Male , Middle Aged , Prevalence , Young Adult
2.
AIDS Behav ; 21(6): 1699-1708, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27380390

ABSTRACT

PHQ-9 data from persons living with HIV (PLWH, n = 4099) being screened for depression in three clinics in the southeastern USA were used to determine the prevalence of suicidal ideation (SI). SI was reported by 352 (8.6 %); associated with <3 years since HIV diagnosis (1.69; 95 %CI 1.35, 2.13), and HIV RNA >50 copies/ml (1.70, 95 %CI 1.35, 2.14). Data from PLWH enrolled in a depression treatment study were used to determine the association between moderate-to-high risk SI (severity) and SI frequency reported on PHQ-9 screening. Over forty percent of persons reporting that SI occurred on "more than half the days" (by the PHQ-9) were assessed as having a moderate-to-high risk for suicide completion during the Mini International Neuropsychiatric Interview. SI, including moderate-to-high risk SI, remains a significant comorbid problem for PLWH who are not fully stabilized in care (as indicated by detectable HIV RNA or HIV diagnosis for less than 3 years).


Subject(s)
Depression/diagnosis , Depressive Disorder/diagnosis , Suicidal Ideation , Suicide/statistics & numerical data , Adult , Comorbidity , Depression/epidemiology , Depression/psychology , Depressive Disorder/epidemiology , Depressive Disorder/psychology , Female , HIV Infections/drug therapy , HIV Infections/psychology , Humans , Male , Mass Screening , Middle Aged , Prevalence , Psychiatric Status Rating Scales , Surveys and Questionnaires , United States/epidemiology
3.
J Acquir Immune Defic Syndr ; 73(4): 482-488, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27668804

ABSTRACT

BACKGROUND: Depression affects 20%-30% of people with HIV. Randomized controlled trials (RCTs) have demonstrated the effectiveness of interventions to improve depression among HIV-infected adults, but typically have highly selected populations which may limit generalizability. Inverse probability of sampling weights (IPSW) is a recently proposed method to transport (or standardize) findings from RCTs to a specific external target population. METHODS: We used IPSW to transport the 6-month effect of the Measurement-Based Care (MBC) intervention on depression from the SLAM DUNC trial to a population of HIV-infected, depressed adults in routine care in the United States between 2010 and 2014. RESULTS: In the RCT, MBC was associated with an improvement in depression at 6 months of 3.6 points on the Hamilton Depression Rating scale [95% confidence interval (CI): -5.9 to -1.3]. When IPSW were used to standardize results from the trial to the target population, the intervention effect was attenuated by 1.2 points (mean improvement 2.4 points; 95% CI: -6.1 to 1.3). CONCLUSIONS: If implemented among HIV-infected, depressed adults in routine care, MBC may be less effective than in the RCT but can still be expected to reduce depression. Attenuation of the intervention effect among adults in routine care reflects the fact that the trial enrolled a larger proportion of individuals for whom the intervention was more effective. Given the burden of depression among HIV-infected adults, more effective interventions to improve depression are urgently needed. However, examining the transportability of trial findings is essential to understand whether similar effects can be expected if interventions are scaled-up.


Subject(s)
Depression/etiology , Depression/therapy , HIV Infections/complications , Adolescent , Adult , Antidepressive Agents/therapeutic use , Cohort Studies , Data Interpretation, Statistical , Female , Humans , Male , Middle Aged , Young Adult
4.
J Affect Disord ; 190: 322-328, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26544615

ABSTRACT

BACKGROUND: Suicidal ideation is the most proximal risk factor for suicide and can indicate extreme psychological distress; identification of its predictors is important for possible intervention. Depression and stressful or traumatic life events (STLEs), which are more common among HIV-infected individuals than the general population, may serve as triggers for suicidal thoughts. METHODS: A randomized controlled trial testing the effect of evidence-based decision support for depression treatment on antiretroviral adherence (the SLAM DUNC study) included monthly assessments of incident STLEs, and quarterly assessments of suicidal ideation (SI). We examined the association between STLEs and SI during up to one year of follow-up among 289 Southeastern US-based participants active in the study between 7/1/2011 and 4/1/2014, accounting for time-varying confounding by depressive severity with the use of marginal structural models. RESULTS: Participants were mostly male (70%) and black (62%), with a median age of 45 years, and experienced a mean of 2.36 total STLEs (range: 0-12) and 0.48 severe STLEs (range: 0-3) per month. Every additional STLE was associated with an increase in SI prevalence of 7% (prevalence ratio (PR) (95% confidence interval (CI)): 1.07 (1.00, 1.14)), and every additional severe STLE with an increase in SI prevalence of 19% (RR (95% CI): 1.19 (1.00, 1.42)). LIMITATIONS: There was a substantial amount of missing data and the exposures and outcomes were obtained via self-report; methods were tailored to address these potential limitations. CONCLUSIONS: STLEs were associated with increased SI prevalence, which is an important risk factor for suicide attempts and completions.


Subject(s)
Depression/psychology , HIV Infections/psychology , Stress, Psychological/psychology , Suicidal Ideation , Suicide, Attempted/psychology , Adult , Attitude to Health , Depression/epidemiology , Female , HIV Infections/epidemiology , Humans , Male , Middle Aged , Prevalence , Risk Factors , Stress, Psychological/epidemiology , Suicide/psychology , Suicide, Attempted/statistics & numerical data , United States/epidemiology
5.
AIDS ; 29(15): 1975-86, 2015 Sep 24.
Article in English | MEDLINE | ID: mdl-26134881

ABSTRACT

BACKGROUND: Depression is a major barrier to HIV treatment outcomes. OBJECTIVE: To test whether antidepressant management decision support integrated into HIV care improves antiretroviral adherence and depression morbidity. DESIGN: Pseudo-cluster randomized trial. SETTING: Four US infectious diseases clinics. PARTICIPANTS: HIV-infected adults with major depressive disorder. INTERVENTION: Measurement-based care (MBC) - depression care managers used systematic metrics to give HIV primary-care clinicians standardized antidepressant treatment recommendations. MEASUREMENTS: Primary - antiretroviral medication adherence (monthly unannounced telephone-based pill counts for 12 months). Primary time-point - 6 months. Secondary - depressive severity, depression remission, depression-free days, measured quarterly for 12 months. RESULTS: From 2010 to 2013, 149 participants were randomized to intervention and 155 to usual care. Participants were mostly men, Black, non-Hispanic, unemployed, and virally suppressed with high baseline self-reported antiretroviral adherence and depressive severity. Over follow-up, no differences between arms in antiretroviral adherence or other HIV outcomes were apparent. At 6 months, depressive severity was lower among intervention participants than usual care [mean difference -3.7, 95% confidence interval (CI) -5.6, -1.7], probability of depression remission was higher [risk difference 13%, 95% CI 1%, 25%), and suicidal ideation was lower (risk difference -18%, 95% CI -30%, -6%). By 12 months, the arms had comparable mental health outcomes. Intervention arm participants experienced an average of 29 (95% CI: 1-57) more depression-free days over 12 months. CONCLUSION: In the largest trial of its kind among HIV-infected adults, MBC did not improve HIV outcomes, possibly because of high baseline adherence, but achieved clinically significant depression improvements and increased depression-free days. MBC may be an effective, resource-efficient approach to reducing depression morbidity among HIV patients.


Subject(s)
Anti-Retroviral Agents/therapeutic use , Antidepressive Agents/therapeutic use , Depression/drug therapy , HIV Infections/complications , HIV Infections/psychology , Medication Adherence , Adult , Female , Humans , Male , Middle Aged , Treatment Outcome
6.
Sex Transm Dis ; 42(1): 54-6, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25504303

ABSTRACT

BACKGROUND: Infectious diseases (ID) clinics are locations where members of at risk social networks, including sex partners of HIV-infected patients, make contact with a medical care setting when they accompany HIV-positive patients to appointments. METHODS: We implemented a free point-of-care rapid HIV testing program for anyone accompanying a patient to the University of North Carolina ID clinic. Acceptability of the program among the general clinic population was assessed via an anonymous survey 1 year after program implementation. Basic frequencies of those who underwent and received results of rapid HIV testing, the proportion of positive rapid tests and confirmatory HIV tests performed, and the level of University of North Carolina ID clinic patient satisfaction with the HIV testing program were calculated. RESULTS: Between October 2007 and June 2013, 450 (99.6%) of 452 individuals tested in the program received their results on the same day as testing. Twenty-two individuals (4.9%) tested HIV positive, of which 16 (72.7%) were newly positive, including 3 never previously tested. Excluding previously diagnosed individuals, HIV prevalence was 3.6% (16/446). Among those testing positive by rapid testing, 19 (86.4%) had confirmatory testing and immediately entered into HIV care at the clinic. CONCLUSIONS: The high positivity and confirmatory HIV rates in our program confirm that the provision of rapid HIV testing in an ID clinic capitalizes on missed opportunities among an at-risk population and allows immediate linkage to care.


Subject(s)
HIV Infections/diagnosis , Academic Medical Centers , Adult , Ambulatory Care Facilities , Appointments and Schedules , Female , HIV Infections/psychology , Humans , Male , Mass Screening , Middle Aged , Patient Acceptance of Health Care/psychology , Patient Satisfaction , Sexual Partners
7.
AIDS Care ; 18 Suppl 1: S45-50, 2006.
Article in English | MEDLINE | ID: mdl-16938674

ABSTRACT

In this study we sought to evaluate sociodemographic and clinical characteristics associated with decreased access to HIV outpatient care in a University-based clinic in the Southeastern U.S. The number of HIV outpatient clinic visits per person-year was estimated among 1,404 HIV-infected individuals participating in a large observational clinical cohort study. On average, participants attended 3.38 visits per person-year (95% CI = 3.32, 3.44), with 71% attending fewer than 4 visits per year. Younger persons, of Black race/ethnicity, with less advanced HIV disease, and a shorter time from entry to HIV care, had poorer access to care, as did participants without health insurance and residing a greater distance from care. Vulnerable subgroups of HIV-infected patients in the South have decreased access to ongoing HIV health care. Interventions including more intensive counseling and active outreach for newly HIV diagnosed individuals and support with obtaining health insurance and transportation may lead to improved outcomes.


Subject(s)
Academic Medical Centers/statistics & numerical data , Ambulatory Care/statistics & numerical data , Delivery of Health Care/statistics & numerical data , Delivery of Health Care/standards , HIV Infections/drug therapy , Health Services Accessibility/economics , Adolescent , Adult , Ambulatory Care/trends , Female , Humans , Middle Aged , Primary Health Care , Socioeconomic Factors , Southeastern United States
SELECTION OF CITATIONS
SEARCH DETAIL
...